Advertisement

Archives of Gynecology and Obstetrics

, Volume 284, Issue 2, pp 503–507 | Cite as

Does laparoscopic ovarian diathermy change clomiphene-resistant PCOS into clomiphene-sensitive?

  • Hatem Abu HashimEmail author
  • Mohamed El-Shafei
  • Ahmed Badawy
  • Alaa Wafa
  • Hosam Zaglol
Reproductive Medicine

Abstract

Purpose

To test the role of laparoscopic ovarian diathermy (LOD) in improving the ovarian response to clomiphene citrate (CC) in clomiphene-resistant polycystic ovary syndrome (PCOS) patients.

Methods

The study comprised of 234 CC-resistant PCOS women who were treated with LOD. Eighty-four patients that remained anovulatory after LOD received 100–150 mg CC for 5 days starting from day 3 of induced menstruation for 1–3 cycles. Outcome measures were; ovulation, pregnancy, miscarriage and live birth rates.

Results

Ovulation occurred in 80/162 cycles (49.4%) and in 30/84 patients (35.7%). Pregnancy occurred in 13/84 patients (15.5%) and in 13/80 cycles (16.2%). Miscarriage and live birth rates were 23.1 and 76.9%, respectively. Ovulatory women showed significantly lower baseline BMI (P < 0.001), Ferriman–Gallwey score (P = 0.02), testosterone (P = 0.03), higher sex hormone binding globulin and lower free androgen index (P < 0.001) compared with anovulatory women. The baseline fasting insulin was statistically significantly lower and fasting glucose:insulin ratio was statistically significantly higher (P = 0.003, 0.002) in ovulatory compared with anovulatory patients.

Conclusions

LOD improves the ovarian response to CC in at least one-third of CC-resistant patients who remained anovulatory following LOD especially in women who are less hyperandrogenic and less insulin resistant.

Keywords

Polycystic ovary syndrome Clomiphene resistance Laparoscopic ovarian diathermy 

Notes

Acknowledgments

The authors would like to thank Dr. M. El Rakhawy MD, senior lecturer and consultant of Diagnostic Radiology, Mansoura, Faculty of Medicine, Mansoura University Hospitals, for his invaluable effort doing transvaginal ultrasound assessment and follow-up of patients enabling completion of this trial report.

Conflict of interest

We declare that we have no conflict of interest.

References

  1. 1.
    Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745–2749. doi: 10.1210/jc.2003-032046 PubMedCrossRefGoogle Scholar
  2. 2.
    Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2008) Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 89:505–522. doi: 10.1016/j.fertnstert.2007.09.041 CrossRefGoogle Scholar
  3. 3.
    Brown J, Farquhar C, Beck J, Boothroyd C, Hughes E (2009) Clomiphene and anti-oestrogens for ovulation induction in PCOS. Cochrane Database Syst Rev (4):CD002249. doi: 10.1002/14651858.CD002249.pub4
  4. 4.
    National Collaborating Centre for Women’s and Children’s Health/National Institue for Clinical Excellence (2004) Fertility: assessment and treatment for people with fertility problems. Clinical Guideline No.11, RCOG Press, London. http://www.nice.org.uk/nicemedia/pdf/CG011niceguideline.pdf
  5. 5.
    Farquhar CM, Williamson K, Gudex G, Johnson NP, Garland J, Sadler L (2002) A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate resistant polycystic ovary syndrome. Fertil Steril 78:404–411. doi: 10.1016/S0015-0282(02)03225-9 PubMedCrossRefGoogle Scholar
  6. 6.
    Bayram N, van Wely M, Kaaijk EM, Bossuyt PM, van der Veen F (2004) Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial. BMJ 328:192. doi: 10.1136/bmj.328.7433.192 PubMedCrossRefGoogle Scholar
  7. 7.
    Farquhar C, Lilford RJ, Marjoribanks J, Vandekerckhove P (2007) Laparoscopic ‘drilling’ by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev (3):CD001122. doi: 10.1002/14651858.CD001122.pub3
  8. 8.
    Felemban A, Lin Tan S, Tulandi T (2000) Laparoscopic treatment of polycystic ovaries with insulated needle cautery: a reappraisal. Fertil Steril 73:266–269. doi: 10.1016/S0015-0282(99)00534-8 PubMedCrossRefGoogle Scholar
  9. 9.
    Api M (2009) Is ovarian reserve diminished after laparoscopic ovarian drilling? Gynecol Endocrinol 25:159–165. doi: 10.1080/09513590802585605 PubMedCrossRefGoogle Scholar
  10. 10.
    Mohiuddin S, Bessellink D, Farquhar C (2007) Long-term follow up of women with laparoscopic ovarian diathermy for women with clomiphene resistant polycystic ovarian syndrome. Aust N Z J Obstet Gynaecol 47:508–511. doi: 10.1111/j.1479-828X.2007.00789.x PubMedCrossRefGoogle Scholar
  11. 11.
    Palomba S, Orio F Jr, Falbo A, Russo T, Caterina G, Manguso F, Tolino A, Colao A, Zullo F (2005) Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligoanovulatory CC-resistant women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 63:631–635. doi: 10.1111/j.1365-2265.2005.02392.x CrossRefGoogle Scholar
  12. 12.
    Kato M, Kikuchi I, Shimaniki H, Kobori H, Aida T, Kitade M, Kumakiri J, Takeuchi H (2007) Efficacy of laparoscopic ovarian drilling for polycystic ovary syndrome resistant to clomiphene citrate. J Obstet Gynaecol Res 33:174–180. doi: 10.1111/j.1447-0756.2007.00504.x PubMedCrossRefGoogle Scholar
  13. 13.
    Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25. doi: 10.1016/j.fertnstert.2003.10.004 Google Scholar
  14. 14.
    World Health Organization (1999) WHO laboratory manual for the examination of human semen and sperm-cervical mucus interactions, 4th edn. Cambridge University Press, CambridgeGoogle Scholar
  15. 15.
    Creanga AA, Bradley HM, McCormick C, Witkop CT (2008) Use of metformin in polycystic ovary syndrome: a meta-analysis. Obstet Gynecol 111:959–968. doi: 10.1097/AOG.0b013e31816a4ed4 PubMedCrossRefGoogle Scholar
  16. 16.
    Polyzos NP, Tzioras S, Badawy AM, Valachis A, Dritsas C, Mauri D (2009) Aromatase inhibitors for female infertility: a systematic review of the literature. Reprod Biomed Online 19:456–471. doi: 10.1016/j.rbmo.2009.06.008 PubMedCrossRefGoogle Scholar
  17. 17.
    Seow KM, Juan CC, Hwang JL, Ho LT (2008) Laparoscopic surgery in polycystic ovary syndrome: reproductive and metabolic effects. Semin Reprod Med 26:101–110. doi: 10.1055/s-2007-992930 PubMedCrossRefGoogle Scholar
  18. 18.
    Branigan EF, Estes MA (2003) A randomized clinical trial of treatment of clomiphene citrate-resistant anovulation with the use of oral contraceptive pill suppression and repeat clomiphene citrate treatment. Am J Obstet Gynecol 188:1424–1430. doi: 10.1067/mob.2003.459 PubMedCrossRefGoogle Scholar
  19. 19.
    Imani B, Eijkemans MJC, te Velde ER, Habbema JD, Fauser BC (1998) Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 83:2361–2365. doi: 10.1210/jc.83.7.2361 PubMedCrossRefGoogle Scholar
  20. 20.
    Karimzadeh MA, Javedani M (2010) An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome. Fertil Steril 94:216–220. doi: 10.1016/j.fertnstert.2009.02.078 PubMedCrossRefGoogle Scholar
  21. 21.
    Imani B, Eijkemans MJ, de Jong FH, Payne NN, Bouchard P, Giudice LC, Fauser BC (2000) Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 85:676–682. doi: 10.1210/jc.85.2.676 PubMedCrossRefGoogle Scholar
  22. 22.
    Parsanezhad ME, Alborzi S, Zarei A, Dehbashi S, Omrani G (2001) Insulin resistance in clomiphene responders and nonresponders with polycystic ovarian disease and therapeutic effects of metformin. Int J Gynaecol Obstet 75:43–50. doi: 10.1016/S0020-7292(01)00470-2 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Hatem Abu Hashim
    • 1
    Email author
  • Mohamed El-Shafei
    • 1
  • Ahmed Badawy
    • 1
  • Alaa Wafa
    • 2
  • Hosam Zaglol
    • 3
  1. 1.Department of Obstetrics and Gynecology, Mansoura Faculty of MedicineMansoura UniversityMansouraEgypt
  2. 2.Division of Diabetes and Endocrinology, Department of Internal Medicine, Mansoura Faculty of MedicineMansoura UniversityMansouraEgypt
  3. 3.Department of Clinical Pathology, Mansoura Faculty of MedicineMansoura UniversityMansouraEgypt

Personalised recommendations